VIGORITA, Maria
 Distribuzione geografica
Continente #
EU - Europa 3.001
NA - Nord America 2.707
AS - Asia 1.429
SA - Sud America 476
AF - Africa 38
OC - Oceania 2
Totale 7.653
Nazione #
US - Stati Uniti d'America 2.665
RU - Federazione Russa 1.501
SG - Singapore 608
CN - Cina 451
BR - Brasile 414
IE - Irlanda 401
SE - Svezia 391
UA - Ucraina 198
DE - Germania 163
HK - Hong Kong 142
FI - Finlandia 77
FR - Francia 72
GB - Regno Unito 70
IT - Italia 63
IN - India 53
VN - Vietnam 50
AR - Argentina 22
CA - Canada 21
PL - Polonia 15
UZ - Uzbekistan 15
MX - Messico 14
ZA - Sudafrica 13
BD - Bangladesh 12
IQ - Iraq 12
IR - Iran 12
TR - Turchia 10
BE - Belgio 8
MA - Marocco 8
CO - Colombia 7
EC - Ecuador 7
ID - Indonesia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
JO - Giordania 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
ES - Italia 5
GR - Grecia 5
JP - Giappone 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
BO - Bolivia 3
LB - Libano 3
MY - Malesia 3
NL - Olanda 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 7.653
Città #
Moscow 443
Dublin 400
Jacksonville 352
Dallas 332
Ashburn 330
Singapore 327
Chandler 275
Nyköping 265
Dearborn 188
Beijing 164
Hong Kong 142
San Jose 92
The Dalles 79
Cambridge 61
Medford 61
Princeton 61
Los Angeles 57
Lauterbourg 52
Ann Arbor 45
Boardman 40
Des Moines 37
Buffalo 33
São Paulo 33
New York 30
Munich 28
Jinan 26
Ho Chi Minh City 24
Tianjin 23
Lancaster 21
San Mateo 21
Guangzhou 14
Warsaw 14
Chennai 13
Tashkent 13
Belo Horizonte 12
Haikou 12
Montreal 12
Phoenix 12
Rio de Janeiro 12
Turku 12
Woodbridge 12
Frankfurt am Main 11
Ardabil 10
Brasília 10
Hanoi 10
Shenyang 10
Wilmington 10
Nanchang 9
Orem 9
Santa Clara 9
Brussels 8
Johannesburg 8
Nanjing 8
Stockholm 8
Denver 7
Seattle 7
Atlanta 6
Bremen 6
Changsha 6
Contagem 6
Guarulhos 6
Hebei 6
Houston 6
London 6
Milan 6
Redondo Beach 6
Turin 6
Amman 5
Asunción 5
Baghdad 5
Boston 5
Brno 5
Campinas 5
Curitiba 5
Dhaka 5
Fuzhou 5
Goiânia 5
Hangzhou 5
Monmouth Junction 5
Ningbo 5
Pune 5
San Francisco 5
Shanghai 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Tokyo 5
Washington 5
Zhengzhou 5
Augusta 4
Brooklyn 4
Helsinki 4
Indore 4
Istanbul 4
Louisville 4
Mumbai 4
New Delhi 4
Norwalk 4
Praia Grande 4
Santo André 4
Totale 4.534
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 244
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 199
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 185
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 182
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 181
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 174
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 170
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 170
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 170
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 169
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 162
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 160
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 157
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 156
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 155
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 155
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 155
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 155
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 147
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 147
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 145
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 144
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 131
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 130
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 122
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 121
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 118
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 117
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 116
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 115
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 113
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 112
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 108
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 104
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 103
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 103
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 102
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 102
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 102
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 101
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 101
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 100
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 99
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 99
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 98
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 97
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 97
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 97
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 95
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 92
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 92
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 90
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 90
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 89
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 86
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 82
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 81
Reattività di isonicotinoilidrazoni con diazometano 75
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 74
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 74
Totale 7.673
Categoria #
all - tutte 23.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021131 0 0 0 0 0 0 0 0 0 53 67 11
2021/2022413 6 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/20251.093 13 9 19 79 42 33 42 212 297 65 107 175
2025/20263.422 180 318 296 241 241 788 438 417 403 100 0 0
Totale 7.673